Pfizer’s latest FDA rebuke is part of a much longer story
Pfizer has become the 12th pharmaceutical company this year to receive an “untitled letter” from the US Food and Drug Administration (FDA) over deceptive drug advertising. But for those who have been following the company closely, the finding was far from surprising. The FDA determined the promotional communications for Adcetris